TrialBMJ open2016

IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial.

Eduard Shantsila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.